<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37696613</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000988</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2023-000988</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the performance of Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in patients with SLE using a Chinese cohort.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Chinese cohort included 352 patients with and 385 without SLE (control group). The clinical data of patients, including demographic data, clinical findings and serological profiles, were collected. Patients with an SLERPI score &gt;7 were classified as SLE. The performance of the American College of Rheumatology (ACR)-1997, Systemic Lupus International Collaborating Clinics (SLICC)-2012 and European League Against Rheumatism (EULAR)/ACR-2019 criteria were used as references.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of these four classification criteria, SLERPI has the highest sensitivity (98.3% (95% CI 96.3% to 99.4%)), but lowest specificity (89.4% (95% CI 85.8% to 92.2%)). In the control group, patients eligible for the classification criteria for SLE were mainly those with primary Sjogren's syndrome (pSS) and undifferentiated connective tissue disease (UCTD), which adversely affected the specificity of the classification criteria. Moreover, significantly more patients with pSS and UCTD met SLERPI than those who met other classification criteria. After excluding patients with pSS and UCTD from the control group, the specificity and accuracy of SLERPI improved to 94.3% (95% CI 91.0% to 96.6%) and 96.5% (95% CI 95.0% to 97.9%), respectively, and both outperformed the EULAR/ACR-2019 criteria. The time to SLERPI classification was the same as their clinical time to diagnosis in 261 patients, earlier than the clinical diagnosis in 23 patients and later than the clinical diagnosis in 9 patients. A total of 280 patients had the same time to SLERPI classification as EULAR/ACR-2019, 8 patients had earlier than EULAR/ACR-2019 and 1 patient had later than EULAR/ACR-2019.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SLERPI performed well in patients with SLE, particularly for the earlier diagnosis of SLE.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Wentian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Hematology, Huzhou Central Hospital, Huzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhichun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Leixi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8415-7088</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China xueleixi2002@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N">East Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="Y">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune Diseases</Keyword><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Lupus Erythematosus, Systemic</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37696613</ArticleId><ArticleId IdType="pmc">PMC10496657</ArticleId><ArticleId IdType="doi">10.1136/lupus-2023-000988</ArticleId><ArticleId IdType="pii">10/2/e000988</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D&#xf6;rner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet 2019;393:2344&#x2013;58. 10.1016/S0140-6736(19)30546-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30546-X</ArticleId><ArticleId IdType="pubmed">31180031</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, D&#xf6;rner T, et al. . Advances in SLE classification criteria. J Autoimmun 2022;132:102845. 10.1016/j.jaut.2022.102845</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102845</ArticleId><ArticleId IdType="pubmed">35725680</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapsala N, Nikolopoulos D, Flouda S, et al. . First diagnosis of systemic lupus erythematosus in hospitalized patients: clinical phenotypes and pitfalls for the non-specialist. Am J Med 2022;135:244&#x2013;53. 10.1016/j.amjmed.2021.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.015</ArticleId><ArticleId IdType="pubmed">34411524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, et al. . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271&#x2013;7. 10.1002/art.1780251101</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780251101</ArticleId><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai A-M, Alarc&#xf3;n GS, et al. . Derivation and validation of the systemic lupus International collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677&#x2013;86. 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et al. . European League against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019;78:1151&#x2013;9. 10.1136/annrheumdis-2018-214819</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214819</ArticleId><ArticleId IdType="pubmed">31383717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W, Tian F, Ma J, et al. . Diagnostic accuracy of the European League against rheumatism/American college of Rheumatology-2019 versus the systemic lupus International collaborating Clinics-2012 versus the ACR-1997 classification criteria in adult systemic lupus erythematosus: A systematic review and meta-analysis. Front Immunol 2022;13:1023451. 10.3389/fimmu.2022.1023451</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1023451</ArticleId><ArticleId IdType="pmc">PMC9599400</ArticleId><ArticleId IdType="pubmed">36311745</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamichou C, Bertsias G. &#x201c;Response to: 'correspondence on 'lupus or not? SLE risk probability index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus' by Batu et Al&#x201d;. Ann Rheum Dis 2023;82:e145. 10.1136/annrheumdis-2021-220262</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-220262</ArticleId><ArticleId IdType="pubmed">33811033</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BCH, Tang I, Bonin J, et al. . The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology Department. Rheumatology (Oxford) 2022;61:4509&#x2013;13. 10.1093/rheumatology/keac120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac120</ArticleId><ArticleId IdType="pmc">PMC9629341</ArticleId><ArticleId IdType="pubmed">35348630</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SR, Brinks R, Costenbader KH, et al. . Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and Ethnicities. Ann Rheum Dis 2020;79:1333&#x2013;9. 10.1136/annrheumdis-2020-217162</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217162</ArticleId><ArticleId IdType="pubmed">32816709</ArticleId></ArticleIdList></Reference><Reference><Citation>Aljaberi N, Nguyen K, Strahle C, et al. . Performance of the new 2019 European League against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus in children and young adults. Arthritis Care Res (Hoboken) 2021;73:580&#x2013;5. 10.1002/acr.24430</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24430</ArticleId><ArticleId IdType="pubmed">32841547</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W, Zhong Y, Weng C, et al. . Utility of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 Classifcation criteria for systemic lupus erythematosus: a single centre retrospective study. Lupus Sci Med 2022;9:e000718. 10.1136/lupus-2022-000718</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2022-000718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufferey P, Meyer OC, Bourgeois P, et al. . Primary systemic Sj&#xf6;gren syndrome (SS) preceding systemic lupus erythematosus: a retrospective study of 4 cases in a cohort of 55 SS patients. Lupus 1995;4:23&#x2013;7. 10.1177/096120339500400106</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339500400106</ArticleId><ArticleId IdType="pubmed">7767334</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Jin Z, Ma L, et al. . Development of clinical decision models for the prediction of systemic lupus erythematosus and Sjogren&#x2019;s syndrome overlap. JCM 2023;12:535. 10.3390/jcm12020535</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020535</ArticleId><ArticleId IdType="pmc">PMC9862529</ArticleId><ArticleId IdType="pubmed">36675463</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavazzana I, Franceschini F, Belfiore N, et al. . Undifferentiated connective tissue disease with antibodies to Ro/Ssa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001;19:403&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11491495</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca M, Neri R, Bencivelli W, et al. . Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years. J Rheumatol 2002;29:2345&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12415590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodolay E, Csiki Z, Szekanecz Z, et al. . Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003;21:313&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">12846049</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Alen J, Alarcon GS, Burgard SL, et al. . Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors. J Rheumatol 1996;23:469&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">8832985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca M, Tani C, Neri C, et al. . Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 2006;6:1&#x2013;4. 10.1016/j.autrev.2006.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2006.03.004</ArticleId><ArticleId IdType="pubmed">17110308</ArticleId></ArticleIdList></Reference><Reference><Citation>Erden A, Apayd&#x131;n H, Fanouriakis A, et al. . Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease. Rheumatology (Oxford) 2022;61:3606&#x2013;13. 10.1093/rheumatology/keac005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac005</ArticleId><ArticleId IdType="pubmed">35015853</ArticleId></ArticleIdList></Reference><Reference><Citation>Doria A, Zen M, Canova M, et al. . SLE diagnosis and treatment: when early is early. Autoimmun Rev 2010;10:55&#x2013;60. 10.1016/j.autrev.2010.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2010.08.014</ArticleId><ArticleId IdType="pubmed">20813207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>